Bracco is an international Group active in the healthcare sector through Bracco Imaging (Diagnostic Imaging), Pharma (prescription and over the counter drugs), Acist Medical Systems (medical devices and advanced imaging agents injection systems based in Minneapolis, USA), and the Centro Diagnostico Italiano diagnostic clinic in Milan.
Its subsidiary Bracco Imaging is one of the world's leading companies in the Diagnostic Imaging.
Bracco Imaging offers a products, injectors and solutions portfolio for all diagnostic applications : X-Ray Imaging (including Computed Tomography-CT), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound, and Nuclear Medicine. Imaging agents are pharmaceutical products aimed at supporting diagnosis and monitoring of various pathologies.
Bracco Imaging is an innovative R&I player with an efficient process oriented approach and a track record of innovation in the Diagnostic Imaging industry. R&D activities are managed in the Research Centers located in Colleretto Giacosa (Italy) and Geneva and Lousanne (Switzerland), Monroe, Minneapolis and the Sillicon Valley (USA). Each Research Center possesses highly specialized expertise in diverse Diagnostic Imaging modalities and techniques.
Additional development expertise and support functions exist in Milan, Beijing, Konstanz (Germany), Montreal (Canada) and Tokyo (Japan). Bracco Imaging also has a number of research collaboration agreements with prestigious University Departments, Hospital-based Research Centers and Biotech Companies in various parts of the world.